Agilvax to Attend 10th Annual BioPharm America & RESI Boston Conferences

ALBUQUERQUE, NM – September 22, 2017 – Agilvax Inc., a biotechnology company that develops targeted cancer immunotherapies and vaccines, announced today that Federica Pericle, President & CEO, will be attending the 10th Annual BioPharm America Conference in Boston, MA, September 26-27, 2017. Additionally, Les Stewart, Chief Operations Officer, will be attending the RESI Boston Conference in Boston, MA, September 26, 2017. Agilvax will be available for one-on-one meetings, and gladly welcomes the opportunity to discuss Agilvax’s immunotherapy and vaccine programs in more detail.